Table 4 Clinical characteristics of post-transplant tuberculosis cases
Case 1 | Case 2 | Case 3 | |
|---|---|---|---|
Age range | 40 - 50 | 40 - 50 | 40 - 50 |
Previous treatment (duration) | Preemptive | HD (4 months) | HD (1 month) |
LDKT or DDKT | LDKT | LDKT | LDKT |
Recipient QFT | Negative | Positive | Negative |
Donor QFT | Positive | Negative | N/A |
Recipient TST | N/A | N/A | 0 mm |
Desensitization | No | No | No |
Induction immunosuppression | Basiliximab | Basiliximab | Basiliximab |
Maintenance immunosuppression | Steroid, tacrolimus, MMF | Steroid, tacrolimus, MMF | Steroid, tacrolimus, MMF |
Time to TB diagnosis after KT | 38 months | 10 months | 7 months |
Type of TB | TB lymphadenopathy | TB colitis | Pulmonary TB |